The candidate's long-term career goal is to become an independent investigator with interdisciplinary expertise in statistical genetics, bioinformatic, and cost-effectiveness analysis to advance individualized colorectal cancer (CRC) prevention in the context of precision medicine. Current guidelines endorse the initiation of screening colonoscopy at age 50 with a 10-year colonoscopy-screening interval for the average-risk population. Although lifestyle, a family history of CRC, and genetic susceptibility influence risk f developing CRC, those factors are not currently incorporated in colonoscopy-screening recommendations. Building on her prior work in colonoscopy screening, the candidate seeks to fill this knowledge gap by optimizing colonoscopy screening according to an individual's lifestyle, family history, and genetic susceptibility. Specifically, the candidate proposes to: 1) develop and validate a risk prediction model for CRC incidence based on lifestyle, family history, and known genetic susceptibility loci;2) determine optimal age of initiation and interval of colonoscopy screening for individuals characterized as high-risk according to this prediction model;3) evaluate the cost- effectiveness of a colonoscopy-screening program tailored according to individual's risk;and 4) identify biological pathways and networks that underlie CRCs that arise despite a negative colonoscopy within 5 years ("interval CRCs"). To achieve these goals, the candidate and her mentors have designed a career development plan for research and educational training to obtain: 1) advanced didactic training in statistical genetics, bioinformatis, and cost-effectiveness analysis;2) practical experience to synthesize data from multiple sources including epidemiological, bioinformatics, and economic data;3) enhanced understanding of CRC etiology and genomics;and 4) extensive analytical skills using pooled data from large consortia. To achieve the proposed research aims, the candidate will utilize two large prospective cohort studies, the Nurses'Health Study (NHS) and the Health Professionals Follow-up Study (HPFS), in which data on endoscopy- screening status have biennially collected among 88,902 participants over the last 26 years. Within these cohorts, a substantial number of participants have been characterized for genetic susceptibility to CRC and cases of CRC have been molecularly profiled. The candidate will also validate findings within the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), which includes a large independent cohort of men and women. The interdisciplinary mentorship and advisory team comprised of national leaders in epidemiology, statistical genetics, bioinformatics, and decision science will provide the requisite expertise to ensure the success of this proposal and the candidate in her critical transition towards an independent investigator. This integrated examination of lifestyle factors, family history, genetic variation, and the molecular interdependency network of interval CRC may lead to the development of more efficacious and cost-effective CRC screening guidelines that can substantially reduce the U.S.'s overall burden of CRC.
Colorectal cancer (CRC) is the third leading cause of cancer death in the United States. Although individual risk for CRC varies according to lifestyle, family history of colorectal cancer, and genetic susceptibility, current guidelines do not consider those factors in colonoscopy-screening recommendations. Thus, we will comprehensively investigate the efficacy and cost-effectiveness of tailoring colonoscopy-screening according to those factors, and identify biological pathways of interval CRCs that arise despite colonoscopy within 5 years.
|Kim, Sun A; Inamura, Kentaro; Yamauchi, Mai et al. (2016) Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis. Br J Cancer 114:199-206|
|Nishi, Akihiro; Milner Jr, Danny A; Giovannucci, Edward L et al. (2016) Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn 16:11-23|
|Mima, Kosuke; Cao, Yin; Chan, Andrew T et al. (2016) Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol 7:e200|
|Ogino, Shuji; Nishihara, Reiko; VanderWeele, Tyler J et al. (2016) Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology 27:602-11|
|Giannakis, Marios; Mu, Xinmeng Jasmine; Shukla, Sachet A et al. (2016) Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep :|
|Cao, Yin; Nishihara, Reiko; Qian, Zhi Rong et al. (2016) Regular Aspirin Use Associates With Lower Risk of ColorectalÂ Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. Gastroenterology 151:879-892.e4|
|Hanyuda, Akiko; Kim, Sun A; Martinez-Fernandez, Alejandro et al. (2016) Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. Ann Surg Oncol 23:908-17|
|Ogino, Shuji; Nishihara, Reiko (2016) All Biomedical and Health Science Researchers, Including Laboratory Physicians and Scientists, Need Adequate Education and Training in Study Design and Statistics. Clin Chem 62:1039-40|
|Song, Mingyang; Nishihara, Reiko; Cao, Yin et al. (2016) Marine Ï‰-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells. JAMA Oncol 2:1197-206|
|McCleary, Nadine J; Sato, Kaori; Nishihara, Reiko et al. (2016) Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer. Clin Cancer Res 22:1489-98|
Showing the most recent 10 out of 31 publications